Tysarbi put on FDA list for possible skin melanoma : Drug Pipeline - This Is MS Multiple Sclerosis Community: Knowledge & Support

View unanswered posts | View active topics

Board index » Multiple Sclerosis » Drug Pipeline

All times are UTC - 8 hours [ DST ]

Tysarbi put on FDA list for possible skin melanoma

Page 1 of 1

[ 1 post ]

Print view

Previous topic | Next topic

Author

Message

gwa

Post subject: Tysarbi put on FDA list for possible skin melanoma

Posted: Fri Sep 05, 2008 2:41 pm

Family Elder

Joined: Thu Dec 01, 2005 4:00 pm
Posts: 846

http://tinyurl.com/5py4qy

Potential Signals of Serious Risks/New Safety Information Identified by the Adverse Event Reporting System (AERS) January - March 2008

Natalizumab (Tysabri) Skin melanomas

This is the list released today for drugs with potential problems.

gwa

Top

Page 1 of 1

[ 1 post ]

Board index » Multiple Sclerosis » Drug Pipeline

All times are UTC - 8 hours [ DST ]

Topics		Author	Replies	Views	Last post
Related topics
	Tysarbi put on FDA list for possible skin melanoma	gwa	0	1127	Fri Sep 05, 2008 2:40 pm gwa
	List of trials	bromley	0	1074	Thu Jun 12, 2008 12:10 pm bromley
	List of current drug trials	Kasuku	1	2017	Tue Dec 13, 2005 1:18 pm dignan
	Rituxan Joins List That Fail for Severe Form of MS	Nemotoday	0	1144	Tue Apr 15, 2008 3:29 pm Nemotoday

Who is online

Users browsing this forum: kostas

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Jump to:

Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!

Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers

This site does not offer, or claim to offer, medical, legal, or professional advice. All treatment decisions should always be made with the full knowledge of your physicians.